How can the EU keep the pace of rapid technological change and evolving healthcare challenges? In this episode of The Break the Bubble podcast, we are joined by Pernille Weiss, former Danish Member of the European Parliament and rapporteur for the EU pharmaceutical legislation directive. Together with our Senior Counsel, Hans Martens, she explores the journey of the General Pharmaceutical Legislation and its future implications. What does it mean to work on such a watershed file? As the new mandate of the European Parliament begins, what is in store for health policy? Is the EU equipped to secure innovation, boost investment in R&D, and be a strong independent player?

This is Break the Bubble!

In an era marked by higher risk of pandemics, natural disasters, and geopolitical tensions, the resilience of health systems becomes ever more crucial. In the latest episode of The Break the Bubble podcast our Senior Counsel, Hans Martens, sits down with Jonathan Cylus, head of the European Observatory on Health Systems and Policies’ London Hub to discuss the main findings of Strengthening Health Systems: A Practical Handbook for Resilience Testing. Among AMR, climate change, and financial crises, which is the most likely threat in the short to medium term? How can we ensure that both health systems and populations remain resilient? Does the private sector play a role? This is Break the Bubble!

In today’s episode, our Senior Counsel, Hans Martens, sits down with former Director General of DG Sante, Anne Bucher, to set the scene for a watershed year not just for health policy in Europe and around the world. With elections filling up the 2024 calendar, what changes can we expect in the EU? And what does this mean for health policy?

In this episode, we explore the concepts of Strategic and Health sovereignty with our Senior Council Hans Martens looking at what they could mean for life science companies operating in Europe. With European elections coming up in 2024 and a continuously evolving international scenario, how can you approach and integrate these concepts into your strategies? Hosted by Gianluca Peinetti, Associate Director at Evoke Incisive Health.

The first episode of Break the Bubble features dives into the measures needed to prevent and address Plasma Derived Medicinal Products (PDMPs) shortages. This episode features the Global Head of Regulatory Policy at the Plasma and Proteins Therapeutics Association, Dominika Misztela who, together with Eduardo Pisani, looks at why PDMPs are essential and unique and how ongoing EU policy and legislative debates can work towards fit-for-purpose solutions.

Break the Bubble is an Evoke Incisive Health podcast.